Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 5.45
+0.15 (2.83%)
Apr 14, 2026, 5:29 PM CET
Mendus AB Market Cap
Mendus AB has a market cap or net worth of 325.15 million as of April 14, 2026. Its market cap has decreased by -4.35% in one year.
Market Cap
325.15M
Enterprise Value
279.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.45
Market Cap Chart
Since April 22, 2013, Mendus AB's market cap has increased from 117.09M to 325.15M, an increase of 177.70%. That is a compound annual growth rate of 8.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 325.15M | -5.18% |
| Dec 30, 2025 | 342.91M | -12.71% |
| Dec 30, 2024 | 392.86M | -12.97% |
| Dec 29, 2023 | 451.43M | -6.06% |
| Dec 30, 2022 | 480.56M | -43.76% |
| Dec 30, 2021 | 854.43M | -30.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 534.43M |
| Corline Biomedical AB | 411.10M |
| Sprint Bioscience AB | 386.19M |
| Ascelia Pharma AB | 376.80M |
| Bio-Works Technologies AB | 344.01M |
| Intervacc AB | 285.94M |
| Elicera Therapeutics AB | 274.23M |
| Xintela AB | 244.60M |